Synthesis and in Vitro Biological Evaluation of Carbonyl Group-containing Analogues for σ1 Receptors

Overview

Journal J Med Chem

Publisher American Chemical Society

Specialty Chemistry

Date 2011 Jul 8

PMID 21732626

Citations 13

Authors

Wei Wang

Jinquan Cui

Xiaoxia Lu

Prashanth K Padakanti

Jinbin Xu

Stanley M Parsons

Robert R Luedtke

Nigam P Rath

Zhude Tu

Affiliations

Soon will be listed here.

Abstract

To identify the ligands for σ(1) receptors that are potent and selective, analogues of prezamicol and trozamicol scaffolds of carbonyl-containing vesicular acetylcholine transporter (VAChT) inhibitors were explored. Of the 23 analogues synthesized and tested, 5 displayed very high affinity for σ(1) (K(i) = 0.48-4.05 nM) and high selectivity for σ(1) relative to σ(2) receptors (σ(1)/σ(2) selectivity of >749-fold). Four of the five compounds (14a, 14b, 14c, and 14e) showed very low affinity for VAChT (K(i) > 290 nM), and the fifth compound (14g) showed moderate affinity for VAChT (K(i) = 44.2 nM). The compound [1'-(4-fluorobenzyl)-3'-hydroxy[1,4']bipiperidinyl-4-yl]-(4-fluorophenyl)methanone (14a) displayed very high affinity and selectivity for σ(1) receptor (K(i) = 0.48 nM, σ(1)/σ(2) > 3600). All four of these most promising compounds (14a, 14b, 14c, and 14e) can be radiosynthesized with fluorine-18 or carbon-11, which will allow further evaluation of their properties as PET probes for imaging σ(1) receptor in vivo.

Citing Articles

The Benzoylpiperidine Fragment as a Privileged Structure in Medicinal Chemistry: A Comprehensive Review.

Bononi G, Lonzi C, Tuccinardi T, Minutolo F, Granchi C Molecules. 2024; 29(9).

PMID: 38731421 PMC: 11085656. DOI: 10.3390/molecules29091930.

Evaluation of [F]F-TZ3108 for PET Imaging of Metabolic-Associated Fatty Liver Disease.

Huang P, Li Z, Peng T, Yang J, Bi L, Huang G Mol Imaging Biol. 2022; 24(6):909-919.

PMID: 35705779 DOI: 10.1007/s11307-022-01740-2.

Piperidinyl Ureas Chemically Control Defective in Cullin Neddylation 1 (DCN1)-Mediated Cullin Neddylation.

Hammill J, Scott D, Min J, Connelly M, Holbrook G, Zhu F J Med Chem. 2018; 61(7):2680-2693.

PMID: 29547696 PMC: 5898815. DOI: 10.1021/acs.jmedchem.7b01277.

Kinetic modeling of [ F]VAT, a novel radioligand for positron emission tomography imaging vesicular acetylcholine transporter in non-human primate brain.

Jin H, Yue X, Liu H, Han J, Flores H, Su Y J Neurochem. 2018; 144(6):791-804.

PMID: 29315563 PMC: 5897141. DOI: 10.1111/jnc.14291.

Synthesis, resolution, and in vitro evaluation of three vesicular acetylcholine transporter ligands and evaluation of the lead fluorine-18 radioligand in a nonhuman primate.

Yue X, Jin H, Liu H, Luo Z, Zhang X, Kaneshige K Org Biomol Chem. 2017; 15(24):5197-5209.

PMID: 28590490 PMC: 5561660. DOI: 10.1039/c7ob00854f.

References

Bourrie B, Bribes E, Derocq J, Vidal H, Casellas P . Sigma receptor ligands: applications in inflammation and oncology. Curr Opin Investig Drugs. 2004; 5(11):1158-63. View

Martin W, EADES C, Thompson J, Huppler R, Gilbert P . The effects of morphine- and nalorphine- like drugs in the nondependent and morphine-dependent chronic spinal dog. J Pharmacol Exp Ther. 1976; 197(3):517-32. View

Chang K, Cuatrecasas P . Heterogeneity and properties of opiate receptors. Fed Proc. 1981; 40(13):2729-34. View

May J, McLaughlin M, Sharif N, Hellberg M, Dean T . Evaluation of the ocular hypotensive response of serotonin 5-HT1A and 5-HT2 receptor ligands in conscious ocular hypertensive cynomolgus monkeys. J Pharmacol Exp Ther. 2003; 306(1):301-9. DOI: 10.1124/jpet.103.049528. View

Antonini V, Prezzavento O, Coradazzi M, Marrazzo A, Ronsisvalle S, Arena E . Anti-amnesic properties of (+/-)-PPCC, a novel sigma receptor ligand, on cognitive dysfunction induced by selective cholinergic lesion in rats. J Neurochem. 2009; 109(3):744-54. DOI: 10.1111/j.1471-4159.2009.06000.x. View

Hayashi T, Su T . An update on the development of drugs for neuropsychiatric disorders: focusing on the sigma 1 receptor ligand. Expert Opin Ther Targets. 2007; 12(1):45-58. DOI: 10.1517/14728222.12.1.45. View

Volz H, Stoll K . Clinical trials with sigma ligands. Pharmacopsychiatry. 2004; 37 Suppl 3:S214-20. DOI: 10.1055/s-2004-832680. View

Blennow K, de Leon M, Zetterberg H . Alzheimer's disease. Lancet. 2006; 368(9533):387-403. DOI: 10.1016/S0140-6736(06)69113-7. View

Kunitachi S, Fujita Y, Ishima T, Kohno M, Horio M, Tanibuchi Y . Phencyclidine-induced cognitive deficits in mice are ameliorated by subsequent subchronic administration of donepezil: role of sigma-1 receptors. Brain Res. 2009; 1279:189-96. DOI: 10.1016/j.brainres.2009.05.004. View

10.

Vilner B, John C, Bowen W . Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines. Cancer Res. 1995; 55(2):408-13. View

11.

John C, Gulden M, Li J, Bowen W, McAfee J, Thakur M . Synthesis, in vitro binding, and tissue distribution of radioiodinated 2-[125I]N-(N-benzylpiperidin-4-yl)-2-iodo benzamide, 2-[125I]BP: a potential sigma receptor marker for human prostate tumors. Nucl Med Biol. 1998; 25(3):189-94. DOI: 10.1016/s0969-8051(97)00168-6. View

12.

Kekuda R, Prasad P, Fei Y, Leibach F, Ganapathy V . Cloning and functional expression of the human type 1 sigma receptor (hSigmaR1). Biochem Biophys Res Commun. 1996; 229(2):553-8. DOI: 10.1006/bbrc.1996.1842. View

13.

Grosse Maestrup E, Wiese C, Schepmann D, Hiller A, Fischer S, Scheunemann M . Synthesis of spirocyclic sigma1 receptor ligands as potential PET radiotracers, structure-affinity relationships and in vitro metabolic stability. Bioorg Med Chem. 2009; 17(10):3630-41. DOI: 10.1016/j.bmc.2009.03.060. View

14.

Megalizzi V, Mathieu V, Mijatovic T, Gailly P, Debeir O, De Neve N . 4-IBP, a sigma1 receptor agonist, decreases the migration of human cancer cells, including glioblastoma cells, in vitro and sensitizes them in vitro and in vivo to cytotoxic insults of proapoptotic and proautophagic drugs. Neoplasia. 2007; 9(5):358-69. PMC: 1877975. DOI: 10.1593/neo.07130. View

15.

Waterhouse R, Stabin M, Page J . Preclinical acute toxicity studies and rodent-based dosimetry estimates of the novel sigma-1 receptor radiotracer [(18)F]FPS. Nucl Med Biol. 2003; 30(5):555-63. DOI: 10.1016/s0969-8051(03)00020-9. View

16.

Brent P, Pang G . Sigma binding site ligands inhibit cell proliferation in mammary and colon carcinoma cell lines and melanoma cells in culture. Eur J Pharmacol. 1995; 278(2):151-60. DOI: 10.1016/0014-2999(95)00115-2. View

17.

Deutsch S, Weizman A, Goldman M, Morihisa J . The sigma receptor: a novel site implicated in psychosis and antipsychotic drug efficacy. Clin Neuropharmacol. 1988; 11(2):105-19. View

18.

Ishikawa M, Sakata M, Ishii K, Kimura Y, Oda K, Toyohara J . High occupancy of sigma1 receptors in the human brain after single oral administration of donepezil: a positron emission tomography study using [11C]SA4503. Int J Neuropsychopharmacol. 2009; 12(8):1127-31. DOI: 10.1017/S1461145709990204. View

19.

Quirion R, Bowen W, Itzhak Y, Junien J, Musacchio J, Rothman R . A proposal for the classification of sigma binding sites. Trends Pharmacol Sci. 1992; 13(3):85-6. DOI: 10.1016/0165-6147(92)90030-a. View

20.

Gao M, Wang M, Hutchins G, Zheng Q . Synthesis of carbon-11-labeled piperidine ring of N-[omega-(6-methoxynaphthalen-1-yl)alkyl] derivatives as new selective PET sigma1 receptor probes. Appl Radiat Isot. 2010; 68(3):459-65. DOI: 10.1016/j.apradiso.2009.12.035. View